Karydas Daphne

Track

Insider profile

Performance

Overall performance
3.3
Performance over holding periods
3.3
30 days 90 days 120 days
Average return 22% 8.2% 15.1%
Success rate 100% 68% 82%
Transactions
2 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Karydas Daphne's trades of Mineralys Therapeutics Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Proposed sale
Price
237.37
Quantity 90,064
Value US$4,941,455
Transaction date
Proposed sale
Price
25.00
Quantity 3,000
Value US$75,000
Transaction date
Proposed sale
Price
25.00
Quantity 3,000
Value US$75,000
Transaction date
Proposed sale
Price
45.99
Quantity 15,000
Value US$689,796
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-09-17 2026-09-15
PlS Planned sale
17,340 +17.2%
96.73
US$3,008,139 		17,340 +17.2% 96.73 US$3,008,139
2026-09-15 2026-09-15
PrS Proposed sale
90,064
237.37
US$4,941,455 		90,064 237.37 US$4,941,455
2026-06-17 2026-06-17
PlS Planned sale
78,895 +48.0%
218.35
US$4,561,840 		78,895 +48.0% 218.35 US$4,561,840
2026-06-17 2026-06-17
PrS Proposed sale
3,000
25.00
US$75,000 		3,000 25.00 US$75,000
2026-04-02 2026-03-31
PlS Planned sale
3,000 -32.6%
25.00
US$75,000 		3,000 -32.6% 25.00 US$75,000
2026-04-02 2026-03-31
PlS Planned sale
3,000 -32.6%
25.00
US$75,000 		3,000 -32.6% 25.00 US$75,000
2026-03-31 2026-03-31
PrS Proposed sale
3,000
25.00
US$75,000 		3,000 25.00 US$75,000
2025-11-13 2025-11-13
PrS Proposed sale
15,000
45.99
US$689,796 		15,000 45.99 US$689,796
2025-11-13 2025-11-13
S Sale
4,885 -100.0%
46.36
US$226,446 		4,885 -100.0% 46.36 US$226,446
2025-11-13 2025-11-13
S Sale
10,115 -67.4%
45.81
US$463,351 		10,115 -67.4% 45.81 US$463,351